Crohn's Disease + is a medical nutrition app for iOS that provides personalized dietary guidelines for Crohn's disease and its comorbidities.
The App DNA
What makes this app unique?
The app removes the cognitive cost of researching complex, evidence-based dietary restrictions by providing an immediate, personalized food-suitability analysis.
For Individuals diagnosed with Crohn's disease or related comorbidities seeking evidence-based, personalized dietary guidance.
What does it look like?
Key features
Nutrition recommendations tailored to Crohn's disease and comorbidities like anemia and osteoporosis.
Interactive tool evaluating if food items are helpful or harmful based on personal health profiles.
Aggregates dietary guidelines from USDA, NIH, and PubMed.
How much does it cost?
The flat-fee model positions the app as a clinical tool rather than a subscription service, though it creates a high barrier to entry.
Velocity
Steady developmentShow more...
Who built it?
Personal Remedies
13+ apps tracked · Medical
Interstitial Cystitis
High Cholesterol
Gout +
High Triglycerides
Lupus +
Food as Medicine
Fatty Liver
Low Histamine Diet +
Kidney Stones - Oxalate
Endometriosis Diet
Rheumatoid Arthritis (RA)
Breast CancerUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Crohn's Disease +
How's the Medical market?
The app occupies a niche medical segment with a $3.99 price point. Its lack of a free tier limits visibility compared to ad-supported health trackers.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Crohn's Disease +
Where is it heading?
The market for condition-specific nutrition is shifting toward integrated, subscription-based care platforms that offer ongoing monitoring. Crohn's Disease + remains exposed to these platforms, as its static, one-time-purchase design lacks the retention loops required to maintain long-term user engagement.
- The app maintains a static, maintenance-only release cadence, which limits its ability to respond to shifting user expectations in the health-tech market.
- The paid-only model restricts user acquisition in a category where free, ad-supported alternatives are increasingly common, leading to stagnant growth.
The SWOT
- Clinical authority via NIH and USDA integration
- Personalized comorbidity management logic
- Localized pricing in high-ARPU international markets
- Partnership programs with gastroenterology clinics
Next best moves
Audit the $3.99 paywall placement because the current conversion rate is low relative to category norms → increase top-of-funnel conversion.
+ 1 more prioritized moveThe counter-intuitive read
The app's clinical-grade data is a liability, not an asset…
Read the full takeSince the last report: The app has shifted from a general medical reference tool to a clinical-grade nutrition guide, formalizing its $3.99 one-time purchase model and identifying the lack of a free-tier preview as a primary barrier to growth.
Bottom line
Transitioning to a freemium model would unlock the top-of-funnel volume needed to compete with free, ad-supported nutrition alternatives, as the current paid-only model limits discovery for users wary of medical app efficacy.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated